Biocon receives EIR for its Biologics Drug Product facility in Bengaluru
Biocon had undergone a surveillance (routine) cGMP inspection of this Drug Product facility in Bengaluru from 22 August to 30 August 2019. The receipt of EIR indicates a successful closure of this inspection.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content